News - Latest

71 news items

Enter search criteria
Fill in keyword(s) to narrow your search.
Period
Sort by:
Subscribe to latest news
  1. Implementation of the Medical Device Regulation postponed until 26 May 2021

    Due to the coronavirus crisis the European Commission has postponed the implementation of the new Medical Device Regulation (MDR, ...

    News item | 08-05-2020 | 17:00

  2. Veterinary Medicinal Products Unit: submit your application digitally

    The Veterinary Medicinal Products Unit (VMPU) requests marketing authorisation holders to submit their applications or reports ...

    News item | 01-05-2020 | 09:00

  3. MEB Portal shut down permanently

    For safety reasons, the MEB portal was provisionally taken offline in January this year. Unfortunately, the MEB has had to take ...

    News item | 20-04-2020 | 12:00

  4. Request to take over the Fucidin marketing authorisation

    The company Leo Pharma B.V. has informed the Medicines Evaluation Board (MEB) that the production of the antibiotic Fucidin ...

    News item | 31-03-2020 | 17:00

  5. Request to take over the pyridoxine hydrochloride marketing authorisation

    The company Pharmachemie B.V. has requested the Medicines Evaluation Board (MEB) to withdraw marketing authorisation for ...

    News item | 30-03-2020 | 17:00

  6. Changes to product information policy

    The Medicines Evaluation Board (MEB) recently revised a number of policy documents for pharmaceutical companies relating to the ...

    News item | 23-03-2020 | 12:00

  7. Coronavirus - MEB employees work from home

    Complying with the Dutch government guidelines regarding the coronavirus situation, MEB employees will be working from home as of ...

    News item | 13-03-2020 | 15:30

  8. Regulatory Science Magazine 10: Reduction, replacement and refinement of animal studies

    This week, the newest edition of the Regulatory Science Magazine was issued. This 10th edition of the online science magazine of ...

    News item | 10-03-2020 | 15:00

  9. Amended policy on DHPCs

    The Medicines Evaluation Board (MEB) has amended its policy on Direct Healthcare Professional Communications (DHPCs). This ...

    News item | 21-02-2020 | 12:00

  10. MEB confirms current legal status of supply ibuprofen 200 mg

    The Medicines Evaluation Board (MEB) has evaluated whether the recent European review of the adverse events on heart and blood ...

    News item | 03-08-2015 | 00:00